Therapeutic Targets on Toxoplasma gondii Parasite in Combatting Toxoplasmosis

References (40)

1. 1 Inhibitors of the Nonmevalonate Pathway of Isoprenoid Biosynthesis as Antimalarial Drugs [DOI]
2. 2 International Journal for Parasitology [DOI]
3. 3 Nuclear-encoded proteins target to the plastid in Toxoplasma gondii and Plasmodium falciparum [DOI]
4. 4 Modulation of innate immunity by Toxoplasma gondii virulence effectors [DOI]
5. 5 Calcium-dependent protein kinase 1 is an essential regulator of exocytosis in Toxoplasma [DOI]
6. 6 Drugs in development for toxoplasmosis: advances, challenges, and current status [DOI]
7. 7 International Review of Cell and Molecular Biology [DOI]
8. 8 Integrative Genomic Approaches Highlight a Family of Parasite-Specific Kinases that Regulate Host Responses [DOI]
9. 9 Communication between Toxoplasma gondii and its host: impact on parasite growth, development, immune evasion, and virulence [DOI]
10. 10 Thiol-based redox metabolism of protozoan parasites [DOI]
11. 11 The apicoplast as an antimalarial drug target [DOI]
12. 12 Toxoplasma gondii calcium-dependent protein kinase 1 is a target for selective kinase inhibitors [DOI]
13. 13 Impact of environmental factors on the emergence, transmission and distribution of Toxoplasma gondii [DOI]
14. 14 TgCDPK3 Regulates Calcium-Dependent Egress of Toxoplasma gondii from Host Cells [DOI]
15. 15 Apicomplexan plastids as drug targets [DOI]
16. 16 Characterization of cytochrome b from Toxoplasma gondii and Qo domain mutations as a mechanism of atovaquone-resistance [DOI]
17. 17 Selective Disruption of Phosphatidylcholine Metabolism of the Intracellular Parasite Toxoplasma gondii Arrests Its Growth [DOI]
18. 18 Activity of fluoroquinolone antibiotics against Plasmodium falciparum in vitro [DOI]
19. 19 The Use and Abuse of Heme in Apicomplexan Parasites [DOI]
20. 20 A Toxoplasma gondii Gluconeogenic Enzyme Contributes to Robust Central Carbon Metabolism and Is Essential for Replication and Virulence [DOI]
21. 21 Bumped Kinase Inhibitor 1294 Treats Established Toxoplasma gondii Infection [DOI]
22. 22 Identification and Development of Novel Inhibitors of Toxoplasma gondii Enoyl Reductase [DOI]
23. 23 Benzoylbenzimidazole-based selective inhibitors targeting Cryptosporidium parvum and Toxoplasma gondii calcium-dependent protein kinase-1 [DOI]
24. 24 Vaccination with Toxoplasma gondii calcium-dependent protein kinase 6 and rhoptry protein 18 encapsulated in poly(lactide-co-glycolide) microspheres induces long-term protective immunity in mice [DOI]
25. 25 Protective immunity against Toxoplasma gondiiinduced by DNA immunization with the gene encoding a novel vaccine candidate: calcium-dependent protein kinase 3 [DOI]
26. 26 Immune responses and protection after DNA vaccination againstToxoplasma gondiicalcium-dependent protein kinase 2 (TgCDPK2) [DOI]
27. 27 Parasiticidal effect of clindamycin on Toxoplasma gondii grown in cultured cells and selection of a drug-resistant mutant [DOI]
28. 28 Trovafloxacin is active against Toxoplasma gondii [DOI]
29. 29 Identification of a novel mitogen-activated protein kinase in Toxoplasma gondii [DOI]
30. 30 Lipid biology of Apicomplexa: perspectives for new drug targets, particularly for Toxoplasma gondii [DOI]
31. 31 Association of host mitochondria with the parasitophorous vacuole during Toxoplasma infection is not dependent on rhoptry proteins ROP2/8 [DOI]
32. 32 Identification of a Secreted Casein Kinase 1 in Leishmania donovani: Effect of Protein over Expression on Parasite Growth and Virulence [DOI]
33. 33 Design, synthesis, and biological activity of diaryl ether inhibitors of Toxoplasma gondii enoyl reductase [DOI]
34. 34 Metabolic pathway analysis and molecular docking analysis for identification of putative drug targets in Toxoplasma gondii: novel approach [DOI]
35. 35 Resistance as a tool in the study of old and new drug targets in Toxoplasma [DOI]
36. 36 Targeting Heat Shock Proteins 60 and 70 of Toxoplasma gondii as a Potential Drug Target: In Silico Approach [DOI]
37. 37 The Rhoptry Proteins ROP18 and ROP5 Mediate Toxoplasma gondii Evasion of the Murine, But Not the Human, Interferon-Gamma Response [DOI]
38. 38 The Proceedings of the National Academy of Sciences [DOI]
39. 39 Antimicrobial agents and chemotherapy—1969 [DOI]
40. 40 Molecular and biochemical parasitology [DOI]

Cited by 9

Showing 3 of 9 known citations — external sources report more than can currently be individually listed.

Related research

• In silico Structural Characterization of Rv3473c from Mycobacterium tuberculosis H37Rv: Potentials in Drug Development — shares topic coverage
• Multi Drug Resistance and Multi Antibiotics Resistance Index of Acinetobacter baumannii Isolated from Hospitals in Port Harcourt Metropolis — shares topic coverage
• Adolescents and Drug Abuse in Tanzania: History and Evolution — shares topic coverage
• Dynamic Modeling of a Futuristic Frame-Based Knowledge Representation Using Unified Modeling Language (UML): A Case of an Intelligent Drug Marketers Tracking System (IDMTS) — shares topic coverage
• Analysis of Thermodynamic Properties of Ranitidine Hydrochloride in Aqueous-sodium Chloride/Sucrose Solutions at 30ºC — shares topic coverage